Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 551

1.

Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.

Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.

PLoS One. 2012;7(1):e29770. doi: 10.1371/journal.pone.0029770. Epub 2012 Jan 5.

2.

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer.

Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S.

PLoS One. 2010 Oct 29;5(10):e13735. doi: 10.1371/journal.pone.0013735.

3.

A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.

Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.

Breast Cancer Res Treat. 2015 Nov;154(2):423-34. doi: 10.1007/s10549-015-3591-0. Epub 2015 Oct 17.

PMID:
26476723
4.

Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.

Kodahl AR, Lyng MB, Binder H, Cold S, Gravgaard K, Knoop AS, Ditzel HJ.

Mol Oncol. 2014 Jul;8(5):874-83. doi: 10.1016/j.molonc.2014.03.002. Epub 2014 Mar 16.

5.

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.

Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.

Dis Markers. 2013;34(3):163-9. doi: 10.3233/DMA-120957.

6.

Circulating microRNAs as specific biomarkers for breast cancer detection.

Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT, Kwong A.

PLoS One. 2013;8(1):e53141. doi: 10.1371/journal.pone.0053141. Epub 2013 Jan 3.

7.

Circulating microRNAs in plasma as early detection markers for breast cancer.

Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, Arlt D, Rath M, Sohn C, Benner A, Junkermann H, Schneeweiss A, Burwinkel B.

Int J Cancer. 2013 Apr 1;132(7):1602-12. doi: 10.1002/ijc.27799. Epub 2012 Sep 14.

8.

Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.

McDermott AM, Kerin MJ, Miller N.

PLoS One. 2013 Dec 31;8(12):e83718. doi: 10.1371/journal.pone.0083718. eCollection 2013.

9.

Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer.

Zhang K, Zhao S, Wang Q, Yang HS, Zhu J, Ma R.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S536-44. doi: 10.1245/s10434-015-4586-0. Epub 2015 May 15.

PMID:
25976861
10.

Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.

Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.

Gene. 2017 Jul 1;619:10-20. doi: 10.1016/j.gene.2017.03.038. Epub 2017 Mar 27.

PMID:
28359916
11.

Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.

Kelly H, Downing T, Tuite NL, Smith TJ, Kerin MJ, Dwyer RM, Clancy E, Barry T, Reddington K.

PLoS One. 2015 Sep 10;10(9):e0137389. doi: 10.1371/journal.pone.0137389. eCollection 2015.

12.

Circulating microRNA-based screening tool for breast cancer.

Frères P, Wenric S, Boukerroucha M, Fasquelle C, Thiry J, Bovy N, Struman I, Geurts P, Collignon J, Schroeder H, Kridelka F, Lifrange E, Jossa V, Bours V, Josse C, Jerusalem G.

Oncotarget. 2016 Feb 2;7(5):5416-28. doi: 10.18632/oncotarget.6786.

13.

miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.

Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ.

J Thorac Oncol. 2011 Mar;6(3):482-8. doi: 10.1097/JTO.0b013e318208c785.

14.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
15.

Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.

McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ, Kerin MJ.

PLoS One. 2014 Jan 31;9(1):e87032. doi: 10.1371/journal.pone.0087032. eCollection 2014.

16.

Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.

Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, Inglada-Pérez L, Martínez-Delgado B, Benítez J.

Clin Chem. 2015 Aug;61(8):1098-106. doi: 10.1373/clinchem.2015.238691. Epub 2015 Jun 8.

17.

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease.

Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ.

Oncologist. 2010;15(7):673-82. doi: 10.1634/theoncologist.2010-0103. Epub 2010 Jun 24.

18.

De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.

Wu X, Somlo G, Yu Y, Palomares MR, Li AX, Zhou W, Chow A, Yen Y, Rossi JJ, Gao H, Wang J, Yuan YC, Frankel P, Li S, Ashing-Giwa KT, Sun G, Wang Y, Smith R, Robinson K, Ren X, Wang SE.

J Transl Med. 2012 Mar 8;10:42. doi: 10.1186/1479-5876-10-42.

19.

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.

van Schooneveld E, Wouters MC, Van der Auwera I, Peeters DJ, Wildiers H, Van Dam PA, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ.

Breast Cancer Res. 2012 Feb 21;14(1):R34.

20.

microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.

Brunet Vega A, Pericay C, Moya I, Ferrer A, Dotor E, Pisa A, Casalots À, Serra-Aracil X, Oliva JC, Ruiz A, Saigí E.

Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

PMID:
23673725

Supplemental Content

Support Center